Gaurav Walia, Vice President of CSV/CSA/DI & Digital Governance, Head of Chicago PQE Office & Sr. Associate Partner, PQE GroupDemonstration of Risk Assessments Concepts Demonstration of Risk Assessments Tools and Strategies Pivoting Away from Traditional Risk Assessments and Encompassing Critical Thinking Pivoting from CSV to CSA with Critical Thinking/Risk Assessment in Mind Real World Highlights […]
By Jane Weitzel, Quality Control Expert, and USP Council of Experts Member & Chair of the 2020-2025 General Chapters –Measurement and Data QualityFit for intended purpose is a key, central concept for USP <1220> Analytical Procedure Life Cycle, ICH Q2(R2) Validation of Analytical Procedures, and ICH Q14 Analytical Procedure Development. The performance criteria for the […]
Kim Huynh-Ba*, Pharmalytik LLC, and Christopher Latoz, Hollister Incorporated*Corresponding Author: kim.huynhba@pharmalytik.comAbstractPharmaceutical products require expiration dates and storage conditions on their labels, determined through stability studies conducted from clinical trials through post-approval. These studies ensure that any chemical, physical, or microbiological changes over time do not affect the product’s quality, safety, or efficacy. ICH Q1A(R2) provides […]
Presented by: Moderator: Chinmoy Roy, Senior Industry Consultant, ValGenesisPanelists: Rosalind Beasley, Chief Executive Officer, Main and Mission Inc.Roy Devine, Global Process Owner Computer System Validation, BDDaniel Walter, Policy Analyst, CDRH, U.S. FDA
Presented by: Leslie Lighton-Humphreys, Senior Manager Compliance and Process Management, Cencora
31 E Kings Highway
2nd Floor Haddonfield, NJ 08033